NUROWN Trademark

Trademark Overview

On Monday, October 18, 2010, a trademark application was filed for NUROWN with the United States Patent and Trademark Office. The USPTO has given the NUROWN trademark a serial number of 85154891. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, April 4, 2025. This trademark is owned by Brainstorm Cell Therapeautics Inc.. The NUROWN trademark is filed in the Pharmaceutical Products category with the following description:

Compositions of cells derived from stem cells for medical purposes; stem cells for medical purposes
nurown

General Information

Serial Number85154891
Word MarkNUROWN
Filing DateMonday, October 18, 2010
Status800 - REGISTERED AND RENEWED
Status DateFriday, April 4, 2025
Registration Number4641441
Registration DateTuesday, November 18, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 23, 2011

Trademark Statements

Goods and ServicesCompositions of cells derived from stem cells for medical purposes; stem cells for medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 21, 2010
Primary Code005
First Use Anywhere DateThursday, July 31, 2014
First Use In Commerce DateThursday, July 31, 2014

Trademark Owner History

Party NameBrainstorm Cell Therapeautics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10019
Party NameBrainstorm Cell Therapeautics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10158
Party NameBrainstorm Cell Therapeautics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events

Event DateEvent Description
Thursday, October 21, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 21, 2010NEW APPLICATION ENTERED
Thursday, January 27, 2011NON-FINAL ACTION E-MAILED
Thursday, January 27, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 18, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 18, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 23, 2011PUBLISHED FOR OPPOSITION
Thursday, January 27, 2011ASSIGNED TO EXAMINER
Thursday, January 27, 2011NON-FINAL ACTION WRITTEN
Tuesday, June 21, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 6, 2011ASSIGNED TO LIE
Saturday, July 16, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 16, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 23, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 24, 2011TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, October 26, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 16, 2012SOU TEAS EXTENSION RECEIVED
Friday, March 16, 2012SOU EXTENSION 1 FILED
Friday, March 16, 2012SOU EXTENSION 1 GRANTED
Tuesday, March 20, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 31, 2011NOTICE OF ALLOWANCE CORRECTION ENTERED
Tuesday, November 1, 2011CORRECTED NOA E-MAILED
Monday, June 18, 2012PAPER RECEIVED
Tuesday, October 9, 2012SOU TEAS EXTENSION RECEIVED
Tuesday, October 9, 2012SOU EXTENSION 2 FILED
Wednesday, October 10, 2012SOU EXTENSION 2 GRANTED
Thursday, October 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 20, 2013SOU EXTENSION 3 FILED
Wednesday, April 10, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 22, 2012APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013SOU TEAS EXTENSION RECEIVED
Thursday, April 11, 2013SOU EXTENSION 3 GRANTED
Friday, April 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 2, 2013SOU TEAS EXTENSION RECEIVED
Wednesday, October 2, 2013SOU EXTENSION 4 FILED
Tuesday, October 8, 2013SOU EXTENSION 4 GRANTED
Wednesday, October 9, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 24, 2014SOU TEAS EXTENSION RECEIVED
Monday, March 24, 2014SOU EXTENSION 5 FILED
Wednesday, April 2, 2014SOU EXTENSION 5 GRANTED
Wednesday, October 15, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 18, 2014REGISTERED-PRINCIPAL REGISTER
Monday, November 18, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 13, 2020TEAS SECTION 8 RECEIVED
Wednesday, October 8, 2014TEAS STATEMENT OF USE RECEIVED
Wednesday, October 8, 2014USE AMENDMENT FILED
Tuesday, October 14, 2014STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 16, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 13, 2020TEAS SECTION 15 RECEIVED
Friday, March 12, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 12, 2021SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Monday, November 18, 2024TEAS SECTION 8 & 9 RECEIVED
Friday, April 4, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 4, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, April 4, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, March 12, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, March 12, 2021REGISTERED - SEC. 15 ACKNOWLEDGED
Friday, March 12, 2021NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Saturday, November 18, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 4, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, July 24, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 24, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 24, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 4, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

nurown cells medical purposes stem from derived compositions